跳至主要内容
临床试验/IRCT20190402043157N1
IRCT20190402043157N1已完成1 期

The effect of combined oral supplementation vitamin D, zinc, calcium and magnesium on glycemic control, lipid profiles, liver enzymes and CRP index in Type 2 diabetic patients

Oroumia University of Medical Sciences0 个研究点目标入组 78 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Adults (18 years of age and under 65 years of age)
  • People with type 2 diabetes who use the same drug (metformin, glibenclamide, metformin-repaglinide).

排除标准

  • Pregnant and lactating people
  • People who are going to have a pregnancy
  • Smoking and alcohol
  • People with polycystic ovary syndrome (if accompanied by type 2 diabetes insulin resistance)
  • Having any underlying heart disease and cancer
  • Species that have kidney, liver and chronic diseases or acute inflammation (especially acute pancreatic inflammation) and thyroid gland diseases
  • Cystic fibrosis (malabsorption)
  • People with gastrointestinal diseases (celiac disease, Crohn's disease, peptic ulcer, diverticulosis, IBD, IBS)
  • People undergoing gastric bypass surgery (malabsorption)
  • People undergoing cholecystectomy (malabsorption)
  • Specimens that were under hormone therapy
  • Insulin injections (due to effect on body weight and insulin levels)
  • Change in the type and dosage of the medications consumed during the intervention
  • Not taking supplements (vitamin D and calcium, etc.) up to three months before the study
  • were treated with drugs and weight loss supplements (such as orlistat or dietary supplements)
  • People who use drugs that cause hyperglycaemia, such as oral or injectable corticosteroids (including prednisone, prednisolone, dexamethasone, triamcinolone, hydrocortisone or betamethasone)
  • People with diabetic foot ulcer
  • Change in the level of physical activity and intense physical activity

研究者

发起方
Oroumia University of Medical Sciences

相似试验